000			01790 a2200541 4500
005			20250515064118.0
264		0	_c20070611
008			200706s 0 0 eng d
022			_a0906-6705
024	7		_a10.1111/j.1600-0625.2007.00550.x _2doi
040			_aNLM _beng _cNLM
100	1		_aOng, C T
245	0	0	_amTOR as a potential therapeutic target for treatment of keloids and excessive scars. _h[electronic resource]
260			_bExperimental dermatology _cMay 2007
300			_a394-404 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aActins _xmetabolism
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aCells, Cultured
650	0	4	_aChild
650	0	4	_aCicatrix, Hypertrophic _xdrug therapy
650	0	4	_aCollagen _xmetabolism
650	0	4	_aCyclin D
650	0	4	_aCyclins _xmetabolism
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFibroblasts _xdrug effects
650	0	4	_aFibronectins _xmetabolism
650	0	4	_aHumans
650	0	4	_aIn Vitro Techniques
650	0	4	_aKeloid _xdrug therapy
650	0	4	_aMale
650	0	4	_aPhosphorylation
650	0	4	_aProliferating Cell Nuclear Antigen _xmetabolism
650	0	4	_aProtein Kinases _xdrug effects
650	0	4	_aRibosomal Protein S6 Kinases, 70-kDa _xmetabolism
650	0	4	_aSirolimus _xadministration & dosage
650	0	4	_aTOR Serine-Threonine Kinases
700	1		_aKhoo, Y T
700	1		_aMukhopadhyay, A
700	1		_aDo, D V
700	1		_aLim, I J
700	1		_aAalami, O
700	1		_aPhan, T T
773	0		_tExperimental dermatology _gvol. 16 _gno. 5 _gp. 394-404
856	4	0	_uhttps://doi.org/10.1111/j.1600-0625.2007.00550.x _zAvailable from publisher's website
999			_c16987874 _d16987874